The latest leukaemia news
A fixed-duration regimen of acalabrutinib in combination with venetoclax, with or without obinutuzumab, has been…
Australian researchers have demonstrated that the use of a new, less toxic drug combination after…
A combination of two drugs could improve outcomes and reduce the need for toxic chemotherapy…
Acute myeloid leukaemia (AML) is an aggressive blood cancer characterised by the uncontrolled proliferation of…
A new gene expression atlas developed using single-cell RNA sequencing data shows how normal hematopoietic…
Patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) who were taking cholesterol-lowering…
A Ludwig Cancer Research study has identified a novel strategy for treating acute myelogenous leukaemia…
A new study, led by Dr. Lisa McKenzie, associate professor in the Department of Environmental & Occupational…
Drug-carrying DNA aptamers can deliver a one-two punch to leukaemia by precisely targeting the elusive…
Researchers have found that the clinical application of BCR::ABL1 digital PCR can reliably quantify stable deep molecular…